The Frost & Sullivan Digital Transformation Blog
A collection of expert insights and industry news to help you accelerate growth.
Featured
Sign Up
Sign up to get Frost & Sullivan’s best
and newest content delivered weekly to your inbox.
Winning the Neuromodulation Race: How to Outpace Competitors and Capture Growth in Neuropsychiatric Care
This blog is based on the detailed analysis, “Frost Radar™: Neuromodulation Devices for Neuropsychiatric Disorders, 2025,” conducted by Frost & Sullivan’s growth experts, Neerj Jadhav and Ashish Kaul, from TechVision Medical Device & Imaging team. The...
Engineering the Future of Medicine: How Next-generation Cell Therapies Are Redefining Precision Healthcare
This blog is based on our analysis, Technological Advances in Engineered Cell Therapies, Global 2025-2029, authored by Frost & Sullivan’s growth experts, Vandana Iyer and Archana Jeevan from the TechVision Health & Wellness team. Engineered cell therapies are...
Frost & Sullivan Released the Report: How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control
New York, USA– Frost & Sullivan has released a white paper titled “How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control” (hereinafter referred to as the “White Paper”). As artificial intelligence becomes central...
Growth Opportunity Newsletter – October 2025 Edition
Find Out How Your Organization Can Capitalize on High-impact Growth Opportunities Redefining the Future of Healthcare, Life Sciences, Energy, Environment, Information & Communications Technology, Mobility, Industrial, Chemicals, Materials, Nutrition, Aerospace,...
BROWSE RECENT POSTS
Frost & Sullivan Released the Report: How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control
New York, USA– Frost & Sullivan has released a white paper titled “How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control” (hereinafter referred to as the “White Paper”). As artificial intelligence becomes central...
Frost & Sullivan Released the Report: How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control
New York, USA– Frost & Sullivan has released a white paper titled “How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control” (hereinafter referred to as the “White Paper”). As artificial intelligence becomes central...
Growth Opportunity Newsletter – October 2025 Edition
Find Out How Your Organization Can Capitalize on High-impact Growth Opportunities Redefining the Future of Healthcare, Life Sciences, Energy, Environment, Information & Communications Technology, Mobility, Industrial, Chemicals, Materials, Nutrition, Aerospace,...
Growth Opportunity Newsletter – October 2025 Edition
Find Out How Your Organization Can Capitalize on High-impact Growth Opportunities Redefining the Future of Healthcare, Life Sciences, Energy, Environment, Information & Communications Technology, Mobility, Industrial, Chemicals, Materials, Nutrition, Aerospace,...
Growth Opportunity Newsletter – October 2025 Edition
Find Out How Your Organization Can Capitalize on High-impact Growth Opportunities Redefining the Future of Healthcare, Life Sciences, Energy, Environment, Information & Communications Technology, Mobility, Industrial, Chemicals, Materials, Nutrition, Aerospace,...
Growth Opportunity Newsletter – October 2025 Edition
Find Out How Your Organization Can Capitalize on High-impact Growth Opportunities Redefining the Future of Healthcare, Life Sciences, Energy, Environment, Information & Communications Technology, Mobility, Industrial, Chemicals, Materials, Nutrition, Aerospace,...
Browse by Category
- All
- Big Data
- Cloud
- Customer Contact
- Consumer
- Digital Media
- Enterprise
- Mobile & Wireless
- The Internet of Things
Opportunity Costs of Complexities: How Telcos can Streamline Processes and Technologies
The telecom business used to be a lot simpler. The networks and operations were large with some complexity, but operators only had voice-dominated landlines to manage. And because of the limited competition, the sales and marketing was simple with just a limited sales channels selling to a narrow range of customers, who did not have much bargaining power. All of this has changed now. Market is more and more segmented and demand is complex, requiring from the operators additional convergence and added value services.
5G Dedicated Access: A New Era of Agile and Scalable Enterprise Connectivity Solutions
5G is witnessing rapid growth in terms of network deployments across the world. Operators are deploying 5G towers to increase their coverage and introducing new bundles and value propositions to support and drive the consumer adoption. As of now, the penetration rate of 5G services among consumer segment of the market is relatively higher than it is for the enterprise segment.
5G Virtual Campus Network: An Immediate Opportunity for Telcos and Organizations
The rise of industry 4.0 is upon us. Organizations are mapping out their digital transformation plans as industries move towards automation and efficient business operators. With the introduction of 5G, this transformation is expected to accelerate as traditional industries are getting better equipped to operate and grow with the benefits 5G promises to offer.
5G a Critical Enabler for Digitalization in Oil and Gas: Emerging Use Cases and Opportunities
Introduction Globally oil and gas industry continues to grow, where gas demand is expected to grow faster at an average of 1.6% year on year till 2024. The oil and gas industry is a front runner on the migration from industry 3.0 to industry 4.0, and rightfully so....
5G Update: It is finally here
After a long hype, telecom operators have finally started going live on their 5G networks.
AR / VR Adoption: Impact on ME Gaming Industry and Opportunities for Telcos
It only took 40 years for the evolution of gaming industry to progress from 4 bit to VR games. Continued shift in demographics, internet and mobile penetration, and the increased availability of gaming infrastructure made it possible.
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
